Regular Hours
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
Valuation Estimation |
EPS (Current/Estimated)
-0.91/0.06
|
Enterprise Value
107.09M
|
Balance Sheet |
Book Value Per Share
0.37
|
Cash Flow |
Cash Flow Yield
--
|
Income Statement |
Total Revenue
24.52M
|
Operating Revenue Per Share
0.35
|
Industry Comparison
|
||||||||||||||||||||||||||||||||||||||||||||||||
|

Industry overview quotes are at least 15 minutes delayed
Business Description
|
|||
ImmunoPrecise Antibodies Ltd is an AI-driven biotherapeutic research, technology and scientifically robust life science company focused on the discovery and development of next-generation biologics. The Company combines scientific expertise with proprietary technologies such as its LENSai platform to accelerate drug discovery and improve decision-making across complex biological systems. IPA has several subsidiaries in North America and Europe, supporting global partners inadvancing novel therapeutics, diagnostics, and translational research. |